Teva Pharma

TEVA Large Cap

Healthcare · Drug Manufacturers - Specialty & Generic

Updated: Apr 5, 2026, 00:03 UTC

$30.08

-0.56% today

52W: $12.47 – $37.35

52W Low: $12.47 Position: 70.8% 52W High: $37.35

🔗 Compare Brokers Best Broker for Beginners →

Key Metrics

P/E Ratio

24.86x

Price-to-Earnings

Forward P/E

9.74x

Forward Price/Earnings

P/S Ratio

2.03x

Price-to-Sales

EV/EBITDA

9.74x

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$35B

Market Capitalization

Revenue Growth

11.4%

YoY Revenue Growth

Profit Margin

8.17%

Net profit margin

ROE

20.79%

Return on Equity

Beta

0.76

Market sensitivity

Short Interest

3.25%

% of float sold short

Avg. Volume

8,957,156

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Strong Buy

11 analysts

Avg. Price Target

$37.82

+25.73% upside

Target Range

$28.00 – $45.00

★ Smart Money Investors

♣ Druckenmiller

This stock is held by one or more of our 15 tracked Smart Money managers. Click a name to view their full portfolio.

About the Company

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of produ

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Country: Israel Employees: 31,173 Exchange: NYQ